A5257
A
Phase III Comparative Study of Three Non-Nucleoside
Reverse Transcriptase Inhibitor (NNRTI)-Sparing Antiretroviral
Regimens for Treatment-Naïve HIV-1-Infected Volunteers
Purpose of this Study: To
compare the virologic efficacy and tolerability of
combination regimens that include FTC/TDF plus RAL,
ATV/r, or DRV/r for treatment of ARV-naïve subjects.
Requirements to Enter Study:
- ARV Naïve; HIV Viral Load >=1000
- Various medical and medication restrictions
Treatment: At entry subjects
will be randomized to one of the following:
All study medications are provided with
the exception of RTV which must be obtained through
a primary care physician. Participants will be reimbursed
for the cost of the RTV co-payment.
Duration of Study: About 2 years after the
last person starts the study.
For
more information contact:
Study
Contacts
Joseph
Quinn, RN (215) 349-8092
